Genocea Biosciences To Present At The UBS Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Jonathan Poole, Chief Financial Officer, will present a company overview at the upcoming UBS Global Healthcare Conference. The presentation is scheduled for Wednesday, May 20, 2015 at 11:00 a.m. EDT in New York, NY.

Help employers find you! Check out all the jobs and post your resume.